Skip to content

N-acetylcysteine review found no clear reduction in kidney injury after contrast

In separate analyses, neither oral nor intravenous N-acetylcysteine showed statistically significant differences in acute kidney injury, dialysis use or mortality; the abstract does not identify the control treatments.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review did not find evidence that N-acetylcysteine, given by mouth or intravenously, reduced acute kidney injury after contrast exposure. It also found no statistically significant differences in dialysis use or mortality. Results remained similar across oral-dose subgroups, but the abstract's missing control-group details and follow-up times limit how specifically the findings can be applied.

Keep in mind

This abstract-based summary cannot identify the control treatments, patient groups, follow-up periods or study-quality assessments. Nonsignificant results leave uncertainty about possible effects, particularly where the reported confidence intervals were wide.

Separate routes, similar uncertainty

The authors analyzed oral and intravenous treatment separately. Neither route showed a statistically significant result for the clinical outcomes reported. Analyses dividing oral treatment into lower and higher doses did not change the reported findings.

What the outcomes mean

The review covered the occurrence of acute kidney injury, the need for haemodialysis and death. These are distinct clinical outcomes with different uncertainty ranges; an inconclusive result for any of them should not be read as proof of equal outcomes.

CHECK THE ORIGINAL

The original publication

N-acetylcysteine as Prophylaxis Against Contrast-Induced Nephropathy: A Meta-Analysis.

Rafique B, Arshad AR, Sabir S et al.
J Coll Physicians Surg Pak · 2026

PubMed ID
42015439
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.